This multibagger pharma stock is down 10% from record high—CFO reveals growth plan

Sivaramakrishnan Chittor, CFO, Sai Life Sciences, said the company continues to see steady progress in the China Plus One opportunity as large pharmaceutical companies diversify their supply chains.